Covid-19 and kidney disease

Miguel et al. Is the Kidney a Target of SARS-CoV-2? Am J Physiol Renal Physiol. 2020 May 15. doi: 10.1152/ajprenal.00160.2020.

Vito et al. Acute Kidney Injury in SARS-CoV-2 Infected Patients Crit Care. 2020 Apr 16;24(1):155. doi: 10.1186/s13054-020-02872-z.

Hernando et al. SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease Kidney Int Rep. 2020 May 1. doi: 10.1016/j.ekir.2020.04.024. Online ahead of print.

Susan et al. SARS-CoV-2 Infection of Kidney Organoids Prevented With Soluble Human ACE2 Nat Rev Nephrol. 2020 Jun;16(6):316. doi: 10.1038/s41581-020-0291-8

Manoocher et al. Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells Int J Mol Sci. 2020 May 5;21(9):E3275. doi: 10.3390/ijms21093275.

Pallares et al. [COVID-19 and Cardiovascular and Kidney Disease: Where Are We? Where Are We Going?] Semergen. 2020 May 11;S1138-3593(20)30144-1.doi: 10.1016/j.semerg.2020.05.005.

Lu et al. Focus on Kidney Disease Among the Coronavirus Disease 2019 Patients: A Comparative Perspective Between China, Italy and the United States Int J Clin Pract. 2020 May 27.doi: 10.1111/ijcp.13561.

Selby et al. Covid-19 and Acute Kidney Injury in Hospital: Summary of NICE Guidelines BMJ. 2020 May 26;369:m1963.doi: 10.1136/bmj.m1963.

Scarpioni et al. Covid-19 and its impact on nephropathic patients: the experience at Ospedale “Guglielmo da Saliceto” in Piacenza. G Ital Nefrol. 2020 Apr 9;37(2). pii: 2020-vol2.

Fu et al. COVID-19 Infection in a Patient with End-Stage Kidney Disease. Nephron. 2020 Mar 27:1-3. doi: 10.1159/000507261.

Choi et al. Renal replacement therapy is independently associated with a lower risk of death in patients with severe acute kidney injury treated with targeted temperature management after out-of-hospital cardiac arrest. Crit Care. 2020 Mar 23;24(1):115. doi: 10.1186/s13054-020-2822-x.

Perico et al. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron. 2020 Mar 23:1-9. doi: 10.1159/000507305.

Zhan et al. The potential risk of kidney vulnerable to novel coronavirus 2019 infection. Am J Physiol Renal Physiol. 2020 Mar 30. doi: 10.1152/ajprenal.00085.2020.

Cheng et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 Mar 20. pii: S0085-2538(20)30255-6. doi: 10.1016/j.kint.2020.03.005.

Henry et al. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020 Mar 28. doi: 10.1007/s11255-020-02451-9.

Calo et al. ACE2 and Prognosis of COVID-19. Insights From Bartter’s and Gitelman’s Syndromes Patients. J Med Virol. 2020 May 6;10.1002/jmv.25978.

PMID: 32374416 PMCID: PMC7267417 DOI: 10.1002/jmv.25978

Maria Francesca et al. The Kidney in COVID-19: Protagonist or Figurant? Panminerva Med. 2020 May 20.

PMID: 32432445 DOI: 10.23736/S0031-0808.20.03965-8

Federico Alberici et al. A Single Center Observational Study of the Clinical Characteristics and Short-Term Outcome of 20 Kidney Transplant Patients Admitted for SARS-CoV2 Pneumonia. Kidney Int. 2020 Jun;97(6):1083-1088.

PMID: 32354634 PMCID: PMC7142691 DOI: 10.1016/j.kint.2020.04.002

Paul Gabarre et al. Acute Kidney Injury in Critically Ill Patients With COVID-19. Intensive Care Med. 2020 Jun 12;1-10.

PMID: 32533197 PMCID: PMC7290076 DOI: 10.1007/s00134-020-06153-9

Meredith Mihalopoulos et al. COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer. Eur Urol Focus. 2020 Jun 9;S2405-4569(20)30160-7.

PMID: 32540268 PMCID: PMC7280142 DOI: 10.1016/j.euf.2020.06.002

Dayal et al. Missing During COVID-19 Lockdown: Children With Onset of Type 1 Diabetes. Acta Paediatr. 2020 Jun 23.

PMID: 32575149 DOI: 10.1111/apa.15443

Gubpta et al. Diabetes and COVID-19: Evidence, Current Status and Unanswered Research Questions. Eur J Clin Nutr. 2020 Jun;74(6):864-870.

PMID: 32404898 PMCID: PMC7220586 DOI: 10.1038/s41430-020-0652-1

Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care. 2020 Jul;43(7):1399-1407

PMID: 32409498 DOI: 10.2337/dc20-0660

Ceriello et al. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era. Diabetes Care. 2020 Jul;43(7):1427-1432.

PMID: 32409501 DOI: 10.2337/dc20-0941

Stafford et al. Pharmacovigilance in Patients With Diabetes: A Data-Driven Analysis Identifying Specific RAS Antagonists With Adverse Pulmonary Safety Profiles That Have Implications for COVID-19 Morbidity and Mortality. J Am Pharm Assoc (2003). 2020 Jun 1;S1544-3191(20)30261-2.

PMID: 32561317 PMCID: PMC7262497 DOI: 10.1016/j.japh.2020.05.018